Market Place
Sourcing Support
FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments
This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s
Sales Forecast of FDA’s Novel Drugs Approvals in 2018
The year 2018 was a landmark year for the US Food and Drug Administration (FDA) as the agency approv
